4
Changes in Ownership
Whitehawk Therapeutics, Inc. Filed Acc 0001415889-24-006414
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 225,768 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lennon David James CHIEF EXECUTIVE OFFICER | 2024-03-01 | Grant or award · Stock option (right to buy) | +30,768 | 30,768 | D | ||
| Lennon David James CHIEF EXECUTIVE OFFICER | 2024-03-01 | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | D | ||
| Lennon David James CHIEF EXECUTIVE OFFICER | 2024-03-01 | Grant or award · Restricted Stock Units | +65,000 | 65,000 | D | ||
Loading xslF345X05/form4-03052024_120318.xml…